Home » Newsletters » BioWorld Science

BioWorld Science

March 8, 2019

View Archived Issues

Decreased inhibition, but no hyperexcitation, in multiple autism models

The Model T of CAR T cells?

Novo Nordisk initiates phase II study of NNC-0174-0833 for weight management

Serum CIRP as novel biomarker for monitoring disease activity in alopecia areata

Exosome therapy for hair loss shows promise

Eli Lilly studies LY-3375880 in phase II trial for moderate to severe atopic dermatitis

BARDA supports development of vaccine against Marburg virus infection

PPT1 inhibition through DC-661 compound shows antitumoral effects

SpringWorks Therapeutics initiates phase III study of nirogacestat

In gut, skin fungus may contribute to IBD

Tyme Technologies adds preclinical candidate to pipeline

Novel noninvasive rodent model of alopecia areata described

New variant of genetic mutation in the ANTXR2 gene found to be associated with hyaline fibromatosis

CBT-509 demonstrates promising efficacy in preclinical cancer models

Pirfenidone partially reverses severe pulmonary arterial hypertension in rat models

Novel tumor microenvironment system based on a 3D human co-culture with patient-derived tumor cells

GlaxoSmithKline and BioVersys divulge new antimycobacterials

Idorsia Pharmaceuticals discloses IDO1 and/or TDO inhibitors

Roche discloses metabotropic glutamate mGlu4 receptor PAMs

Agios Pharmaceuticals patents PKLR activators

European approval for Tecentriq with Avastin and chemotherapy for metastatic non-squamous NSCLC

Pfizer identifies TYK2 inhibitors

HOXC6 gene expression linked to cervical cancer progression

Helsinn opens phase III program with anamorelin to treat weight loss and anorexia in NSCLC cachexia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Hippocratic loath? ‘Harm’ threat from ACIP’s proposed HBV shift
BioWorld
Individual liberty and choice vs. wider public health became one predictable hinge upon which swung the often-acerbic debates at the CDC’s Advisory Committee for...
Høeg appointment as acting CDER director tied to vaccine strategy?
BioWorld
After a more than 13-year period of stability with Janet Woodcock as the head of CDER, with Patrizia Cavazzoni taking charge during the next four years of former...
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...